Home LiteratureArticle Details
PMID: 970989 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.

Annals of the rheumatic diseases ·Vol. 35 ·No. 4 ·1976-08-00 ·Pages 321-6

Schroeter AL, Conn DL, Jordon RE

Abstract

Rheumatoid arthritis (RA) was differentiated from systemic lupus erythematosus (SLE) by direct immunofluorescent techniques on skin specimens, using monospecific antisera for IgG, IgM, C3, C1q, properdin, and fibrin. Of 30 patients with RA studied, 20 had dermal vessel deposits of immunoglobulins and complement components in unaffected skin without the characteristic dermal-epidermal junctional fluorescence of SLE. Of 24 SLE patients studied, 24 had granular deposits of immunoglobulins and complement components in unaffected skin at the dermal-epidermal junction.

MeSH Terms
Arthritis, Rheumatoid/immunology Complement C1/analysis Complement C3/analysis Complement System Proteins/analysis Fibrin/analysis Humans Immunoglobulin G/analysis Immunoglobulin M/analysis Immunoglobulins/analysis Lupus Erythematosus, Systemic/immunology Middle Aged Properdin/analysis Skin/immunology
Chemicals
Complement C1 Complement C3 Immunoglobulin G Immunoglobulin M Immunoglobulins Properdin Fibrin Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schroeter A L
Conn D L
Jordon R E
References (26)
26 references, click to expand
  1. IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.
    J Exp Med. 1964 Feb 1;119:195-209 PMID: 14164478
  2. Dermal-epidermal deposition of complement components and properdin in systemic lupus erythematosus.
    Br J Dermatol. 1975 Mar;92(3):263-71 PMID: 1096924
  3. 1958 Revision of diagnostic criteria for rheumatoid arthritis.
    Bull Rheum Dis. 1958 Dec;9(4):175-6 PMID: 13596783
  4. Peripheral vascular obstruction in rheumatoid arthritis and its relationship to other vascular lesions.
    Ann Rheum Dis. 1957 Mar;16(1):84-103 PMID: 13412011
  5. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis.
    Ann Intern Med. 1957 May;46(5):831-51 PMID: 13411894
  6. Localization of various plasma proteins in the skin in rheumatoid arthritis. An immunofluorescent microscopic study of skin biopsies.
    Acta Med Scand. 1972 Jul-Aug;192(1-2):13-9 PMID: 4115291
  7. Glomerular and dermal depostion of properdin in systemic lupus erythematosus.
    N Engl J Med. 1972 Oct 5;287(14):681-5 PMID: 4115613
  8. Studies into the occurrence of soluble antigen-antibody complexes in disease. V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis.
    Arthritis Rheum. 1973 Mar-Apr;16(2):225-30 PMID: 4123762
  9. Role of IgG and IgM antinuclear antibodies in formation of lupus erythematosus cells and extracellular material.
    Arthritis Rheum. 1970 Nov-Dec;13(6):786-97 PMID: 4099834
  10. Properties of highly purified human properdin.
    J Immunol. 1968 Jan;100(1):142-58 PMID: 4169693
  11. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis.
    Am J Med. 1969 Jul;47(1):23-35 PMID: 4183354
  12. Dermal-epidermal junction in lupus erythematosus.
    Arch Dermatol. 1969 Jun;99(6):652-62 PMID: 4181911
  13. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
    N Engl J Med. 1969 Jun 19;280(25):1376-81 PMID: 4181609
  14. Procedures for the immunization of goats with human immunoglobulins and complement.
    Int Arch Allergy Appl Immunol. 1970;38(3):315-9 PMID: 4190252
  15. The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation.
    Clin Immunol Immunopathol. 1975 Jan;3(3):307-14 PMID: 45850
  16. Immunopathologic study of sural nerves in rheumatoid arthritis.
    Arthritis Rheum. 1972 Mar-Apr;15(2):135-43 PMID: 4337482
  17. 7S M-globulin in rheumatoid arthritis. Evaluation of its clinical significance.
    Arthritis Rheum. 1971 Jul-Aug;14(4):440-50 PMID: 4327635
  18. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    J Clin Invest. 1973 Jul;52(7):1779-87 PMID: 4352464
  19. Hypocomplementemia in rheumatoid arthritis.
    Am J Med. 1973 Apr;54(4):461-72 PMID: 4633106
  20. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    J Clin Invest. 1974 May;53(5):1434-40 PMID: 4596508
  21. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    J Clin Invest. 1974 Aug;54(2):297-309 PMID: 4847246
  22. IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.
    Arthritis Rheum. 1974 May-Jun;17(3):272-84 PMID: 4825647
  23. Immunologic factors and clinical activity in systemic lupus erythematosus.
    N Engl J Med. 1968 Mar 7;278(10):533-8 PMID: 4866347
  24. Immunofluorescence of the skin in patients with rheumatoid arthritis. A preliminary report.
    Dermatologica. 1967;134(5):351-5 PMID: 4862184
  25. Further speculation on the pathogenesis of joint inflammation in rheumatoid arthritis.
    Arthritis Rheum. 1970 Nov-Dec;13(6):895-901 PMID: 5312903
  26. THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES.
    J Invest Dermatol. 1963 Dec;41:451-6 PMID: 14085466
Article Info
Journal
Annals of the rheumatic diseases
Abbr.
Ann Rheum Dis
ISSN
0003-4967
Published
1976-08-00
Pages
321-6
Language
English
Region
England
NLM ID
0372355
PMCID
PMC1007389
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]